Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Optimization and Clinical Validation of a Pathogen Detection Microarray

ABSTRACT: This series includes microarrays from 36 patient samples and 2 cell-culture controls, used to optimize and validate the pathogen detection microarray (Wong, et. al. 2007) Keywords: viral pathogen detection

OTHER RELATED OMICS DATASETS IN: PRJNA99799

ORGANISM(S): Severe acute respiratory syndrome-related coronavirus Viruses dengue virus type 1

PROVIDER: GSE7779 | GEO | 2007/05/29

SECONDARY ACCESSION(S): PRJNA99799

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

Optimization and Clinical Validation of a Pathogen Detection Microarray

Project description:Optimization and Clinical Validation of a Pathogen Detection Microarray

| PRJNA99799 | ENA

Optimization and clinical validation of a pathogen detection microarray.

Project description:DNA microarrays used as 'genomic sensors' have great potential in clinical diagnostics. Biases inherent in random PCR-amplification, cross-hybridization effects, and inadequate microarray analysis, however, limit detection sensitivity and specificity. Here, we have studied the relationships between viral amplification efficiency, hybridization signal, and target-probe annealing specificity using a customized microarray platform. Novel features of this platform include the development of a robust algorithm that accurately predicts PCR bias during DNA amplification and can be used to improve PCR primer design, as well as a powerful statistical concept for inferring pathogen identity from probe recognition signatures. Compared to real-time PCR, the microarray platform identified pathogens with 94% accuracy (76% sensitivity and 100% specificity) in a panel of 36 patient specimens. Our findings show that microarrays can be used for the robust and accurate diagnosis of pathogens, and further substantiate the use of microarray technology in clinical diagnostics.

| S-EPMC1929155 | biostudies-literature

DNA microarray for STD pathogen detection

Project description:DNA microarray for STD pathogen detection

| PRJNA285757 | ENA

Clinical Pathogen Surveillance

Project description:Clinical Pathogen Surveillance

| PRJNA171937 | ENA

Chromosomal microarray analysis for validation of the NGS-based CNV detection results in clinical samples

Project description:In order to evaluate the performance of CNV detection in next-generation sequencing platform in varied sample types, we employed chromosomal microarray analysis (CMA) for validation of the samples with NGS-based detection results (NCBI Sequence Read Archive with accession number SRA296708). Besides array Comparative Genomics Hybridization (aCGH, Agilent) , we used a commerical SNP-array (Illumina) including early abortus, induced termination, prenatal samples and postnatal samples. CMA results were compared with NGS-based detection results. 100% consistency was obtained between NGS-based approach and CMA in pathogenic or likely pathogenic CNVs detection.

2015-10-01 | GSE73190 | GEO

A Versatile Sample Processing Workflow for Metagenomic Pathogen Detection

Project description:A Versatile Sample Processing Workflow for Metagenomic Pathogen Detection

| PRJEB27711 | ENA

Optimization of redox metabolite detection in mammalian cells (part II)

Project description:Conditions were tested to optimize number of cells and extraction buffer for the detection of redox reactive metabolites from mammalian cells. Four different extraction buffers were compared. Derivatization of glutathion was explored as a condition as well.

2021-04-22 | ST001772 | MetabolomicsWorkbench

The Microbial Detection Array Combined with Random Phi29-Amplification used as a Diagnostic Tool for Unbiased Virus Detection in Clinical Samples

Project description:A common technique used for sensitive and specific diagnostic virus detection in clinical samples is PCR. However, an unbiased diagnostic microarray containing probes for all human pathogens could replace hundreds of individual PCR-reactions and remove the need for a clear clinical hypothesis regarding a suspected pathogen. We have established such a diagnostic platform for unbiased random amplification and subsequent microarray identification of viral pathogens in clinical samples. We show that Phi29 polymerase-amplification of a diverse set of clinical samples generates enough viral material for successful identification by the Microbial Detection Array developed at the Lawrence Livermore National Laboratory, California, USA, demonstrating the potential of the microarray technique for broad-spectrum pathogen detection. We conclude that this method detects both DNA and RNA virus, present in the same sample, as well as differentiates between different virus subtypes. We propose this assay for unbiased diagnostic analysis of all viruses in clinical samples.

2011-04-14 | GSE28597 | GEO

Clinical pathogenic bacteria detection

Project description:Clinical pathogenic bacteria detection

| PRJEB46246 | ENA

Optimization of redox metabolite detection in mammalian cells (part I)

2021-04-21 | ST001765 | MetabolomicsWorkbench